S-C07
Preventing Relapse After HCT

Track: BMT Tandem "Scientific" Meeting
Saturday, March 1, 2014: 10:30 AM-12:00 PM
Texas D (Gaylord Texan)
Chair:
Marcos J. G. de Lima, MD

Disclosures:
M. J. G. de Lima, celgene, none: Consultancy

Minimal Residual Disease
Christopher S. Hourigan, MD, PhD, National Heart, Lung, and Blood Institute

Post Autologous Transplant Therapy
Philip L. McCarthy, MD, Roswell Park Cancer Institute

Maintenance Therapy in Allogeneic Transplants
Marcos J. G. de Lima, MD, University Hospitals / Case Western Reserve University